Tekcis

Tekcis (Pertechnetate Tc-99m Sodium) is a radiopharmaceutical used in nuclear medicine imaging. It is administered intravenously for diagnostic procedures. This sterile, non-pyrogenic solution supports imaging of organs and tissues. Suitable for adults and pediatric patients when prescribed.

Pertechnetate (99mTc) Sodium is primarily used in diagnostic imaging to visualize thyroid, salivary glands, and other tissues. It aids in detecting abnormalities such as tumors or cysts. The radiopharmaceutical is also used in blood pool imaging and sentinel lymph node mapping. Commonly prescribed for functional studies of organs like the heart and brain.

After intravenous administration, Pertechnetate (99mTc) Sodium distributes throughout the body, highlighting areas of interest for imaging. Patients may experience mild discomfort at the injection site. The effects are temporary and tied to the imaging process, with results typically available within hours.

Handle with care due to its radioactive nature; follow local radiation safety guidelines. Avoid direct contact with skin or mucous membranes. Pregnant or breastfeeding individuals should consult a healthcare provider before use. Ensure proper disposal according to regulatory standards.

No known drug interactions have been established for Pertechnetate (99mTc) Sodium. However, recent use of thyroid medications or contrast agents may affect imaging results. Patients should inform their healthcare provider about all medications and supplements. Alcohol and certain foods do not typically interfere with the diagnostic process.